Skip to content

Specturi Device - Feasibility Study

Specturi Device Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03105557
Enrollment
20
Registered
2017-04-10
Start date
2020-01-27
Completion date
2025-02-05
Last updated
2026-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rickets

Keywords

Prematurely born newborns, Urine, Collecting device

Brief summary

On a daily basis many (prematurely born) newborn are subjected to different urine collecting techniques to study biochemical abnormalities. Neonatology nurses and pediatricians are looking for a better and less invasive manner to collect urine in these vulnerable patients. We hypothesise that the urine collecting device as presented in this protocol is less invasive and has good functional abilities to collect urine in these newborns Objective of the study: Clinical feasibility of the urine collection device, indicated by staff and parents. Study design: The study will be an open label, clinical feasibility study, of the urine collection device. During a period of 6 months, 30 feasibility tests will be performed. Study population: Prematurely born newborns, admitted to the neonatology unit of the department of pediatrics at Rijnstate Hospital Arnhem.

Interventions

DEVICEUrinary collecting device

Urinary collecting device

Sponsors

Capturin Distribution B.V.
Lead SponsorINDUSTRY
Fonds NutsOhra
CollaboratorOTHER
FrieslandCampina
CollaboratorINDUSTRY
Rijnstate Hospital
CollaboratorOTHER
Scint B.V.
CollaboratorUNKNOWN
Hertog Hendrik BV
CollaboratorUNKNOWN
University of Twente
CollaboratorOTHER
Radboud University Medical Center
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Neonates admitted to the neonatology unit of the paediatrics department of Rijnstate Hospital Medical indication for urine testing for Calcium, Phosphate and Creatinine levels Informed consent from parents

Exclusion criteria

* No informed consent * Defective skin in genital region * Three previous tests in the same subject

Design outcomes

Primary

MeasureTime frameDescription
Questionnaire based clinical feasibility of the urine collection device, indicated by staff and parents1 dayWith concern to feasibility we want to know whether this device is able: * easy to apply to the neonate * to only collect urine * to exclude stool admixture * easy to use by the nurses * comfortable for te neonates

Secondary

MeasureTime frameDescription
Skin reactions1 weekNumber of times skin reactions occurs, reported by the responsible nurse
Skin irritability1 weekNumber of times skin irritability occurs, reported by the responsible nurse

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026